Prof Nancy Devlin
@prof-nancy-devlin.bsky.social
Editor in Chief at Value in Health, Board chair at EuroQol Research Foundation, Rotterdam & Professor of Health Economics at University of Melbourne. Proud mum of three wonderful adults and grandma to two very energetic tiny humans.
in a good way, though, I hope! :-)
July 28, 2025 at 1:44 AM
in a good way, though, I hope! :-)
Thank you!! 👍
June 18, 2025 at 11:32 AM
Thank you!! 👍
Nice work @lauratrigg.bsky.social! 🙌 We need to see much more of this kind of evidence on the cost effectiveness of existing healthcare interventions. b.t.w,@jappleby123.bsky.social @koonalshah.bsky.social looked at hip surgery in 2013, using NHS PROMS data: pubmed.ncbi.nlm.nih.gov/23759892/
Using patient-reported outcome measures to estimate cost-effectiveness of hip replacements in English hospitals - PubMed
Using the new patient-assessed health-related quality of life data combined with routine hospital-level cost data it is possible to estimate a procedure-based measure of efficiency for hospitals. The ...
pubmed.ncbi.nlm.nih.gov
May 17, 2025 at 3:37 PM
Nice work @lauratrigg.bsky.social! 🙌 We need to see much more of this kind of evidence on the cost effectiveness of existing healthcare interventions. b.t.w,@jappleby123.bsky.social @koonalshah.bsky.social looked at hip surgery in 2013, using NHS PROMS data: pubmed.ncbi.nlm.nih.gov/23759892/
[2/2] So, after the 10-year exclusivity period ends, what happens? Not much: despite expectations of price reductions, the authors observe that many orphan meds seem to lack competition.
@amsterdamumc.bsky.social
This 'Editor's Choice' paper is available open access: tinyurl.com/EUOrphanMeds
@amsterdamumc.bsky.social
This 'Editor's Choice' paper is available open access: tinyurl.com/EUOrphanMeds
May 12, 2025 at 4:36 AM
[2/2] So, after the 10-year exclusivity period ends, what happens? Not much: despite expectations of price reductions, the authors observe that many orphan meds seem to lack competition.
@amsterdamumc.bsky.social
This 'Editor's Choice' paper is available open access: tinyurl.com/EUOrphanMeds
@amsterdamumc.bsky.social
This 'Editor's Choice' paper is available open access: tinyurl.com/EUOrphanMeds